Dr. Athiya Agarwal has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Athiya Agarwal (mother) acquired 21,15,180 shares (0.67% of diluted share capital) of Dr. Agarwal's Health Care Limited from Dr. Anosh Agarwal (son) on 4 March 2026 by way of a gift. Both belong to the promoter and promoter group, and no monetary consideration was involved. Following the transfer, Dr. Athiya Agarwal's holding rose from 3.33% (1,05,46,795 shares) to 4.00% (1,26,61,975 shares), while Dr. Anosh Agarwal's holding declined from 5.36% to 4.69%. The total promoter group shareholding remains unchanged as this is only an internal reshuffle. The transaction qualifies for an exemption under Regulation 10(1)(a)(i) of SEBI (SAST) Regulations, 2011, meaning no open offer obligation is triggered.
This is a routine internal family arrangement within the promoter group with no change in overall promoter shareholding and no cash transaction, so it is largely neutral for the stock. It does signal a consolidation of shares in the elder family member's name but should not affect minority shareholders or trigger any open offer.